The caffeine metabolic ratio as an index of xanthine oxidase activity in clinically active and silent celiac patients

Journal of Pediatric Gastroenterology and Nutrition

Volumn 29, Issue 5, 1999, Pages 546-550

  Boda, Márta ^a   Németh, Ilona ^a   Boda, Domokos ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Celiac disease; Celiac disease, active form; Free radicals; Silent form; Xanthine oxidase

Indexed keywords

CAFFEINE; IRON; XANTHINE OXIDASE;

ARTICLE; CELIAC DISEASE; CLINICAL ARTICLE; COFFEE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME ANALYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTESTINE BIOPSY; MALE; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

CAFFEINE; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; IRON; MALE; URIC ACID; XANTHINE OXIDASE; XANTHINES;

EID: 0342699475     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199911000-00014     Document Type: Article

References (29)

1. Parks AD, Granger DN. Xanthine oxidase: Biochemistry, distribution and physiology. Acta Physiol Scand Suppl 1986;548:87-99.
2. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol 1988;255:H1269-75.
3. Friedl HP, Smith DJ, Till GO, Thomson PD, Louis DS, Ward PA. Ischemia-reperfusion in humans: Appearance of xanthine oxidase activity. Am J Pathol 1990;136:491-5.
4. Sarnesto A, Linder N, Raivio KO. Organ distribution and molecular forms of human xanthine dehydrogenase/xanthine oxidase protein. Lab Invest 1996;74:48-56.
5. Hellstein-Weting Y. Immunohistochemical localization of xanthine oxidase in human cardiac and skeletal muscle. Histochemistry 1993;100:215-22.
6. Friedl HP, Smith DJ, Till GO, Thomson PD, Louis DS, Ward PA. Ischemia-reperfusion in humans: Appearance of xanthine oxidase activity. Am J Pathol 1990;136:491-5.
7. Saugstad OD. Role of xanthine oxidase and its inhibitor in hypoxia: Reoxygenation injury. Pediatrics 1996;98:103-7.
8. Parks DA, Bulkey GB, Granger DN. Role of oxygen-derived free radicals in digestive tract diseases. Surgery 1983;94:415-22.
9. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986; 251:G567-73.
10. Suzuki M, Grisham MB, Granger DN. Leukocyte-endothelial cell adhesive interactions: Role of xanthine oxidase-derived oxidants. J Leukoc Biol 1991;50:488-94.
11. Ghezzi P, Bianchi M, Mantovani A, et al. Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducers. Biochem Biophys Res Commun 1984;119:144-9.
12. Friedl HP, Till GO, Ryan US, Ward PA. Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J 1989;3: 2512-8.
13. Grant DM, Tang BK, Kalow W. Variability in caffeine metabolism. Clin Pharmacol Ther 1983;33:591-602.
14. Grant DM, Tang BK, Campbell ME, Kalow W. Effect of allopurinol on caffeine disposition in man. Br J Clin Pharmacol 1986; 21:454-8.
15. Kalow W, Tang BK. Use of caffeine metabolic ratios to explore CYP1A2 and xanthine oxidase activities. Clin Pharmacol Ther 1991;50:508-19.
16. Ferguson A, Arranz F, O'Mahony S. Clinical and pathological spectrum of coeliac disease-active, silent, latent, potential. Gut 1993;34:150-1.
17. Catassi C, Fabiani E. The spectrum of coeliac disease in children. Baillieres Clin Gastroenterol 1997;11:485-507.
18. Pena AS, Crusius JB. Food allergy, coeliac disease and chronic inflammatory bowel disease in man. Vet Q 1998;20(Suppl 3):S49-52.
19. Pena AS, Garrote JA, Crusius JB. Advances in the immunogenetics of coeliac disease: Clues for understanding the pathogenesis and disease heterogeneity. Scand J Gastroenterol Suppl 1998;225: 56-58.
20. Salk B, Webb K, Guayan PM, et al. Aberrant free radical activity in cystic fibrosis. Clin Chim Acta 1989;101:65-74.
21. Shiratora Y, Anki S, Takada H, Kiriyana H, Ohio K. Oxygen-derived free radical generating capacity of polymorphonuclear cells in patients with ulcerative colitis. Digestion 1989;44:163-71.
22. Wisser JR, Renner JG. Allopurinol attenuates caerulein induced acute pancreatitis in the rat. Gut 1988;29:926-9.
23. Odetti P, Valentini S, Aragno I, et al. Oxidative stress in subjects affected by celiac disease. Free Radic Res 1998;29:17-24.
24. Kilbane AJ, Silbart LK, Manis M, Beitins IZ, Weber WW. Human N-acetylation genotype determination with urinary caffeine metabolites. Clin Pharmacol Ther 1990;47:470-7.
25. Pickett JP, Pendergrass RE, Bredford, Elshepp JG. Localization of xanthine oxidase in rat duodenum: Fixation of sections instead of blocks. Stain Technol 1970;45:35-6.
26. Marsh MN. Mucosal pathology in gluten sensitivity. In: Marsh MN, ed. Coeliac disease. Oxford, UK: Blackwell Scientific Publications 1995:136-91.
27. Chowers Y, Marsh MN, De Granpe L, Nyberg A, Theofilopoulos AN, Kagnoff MF. Increased proinflammatory cytokine gene expression in the colonic mucosa of coeliac disease patients in the early period after gluten challenge. Clin Exp Immunol 1997;107: 141-7.
28. Nilsen EM, Lundin KE, Krajci P, Scott H, Sollid LM, Brandtzaeg P. Gluten specific, HLA-DQ restricted T cells from coeliac mucosa produce cytokines, with Th1 or Th0 profile dominated by interferon gamma. Gut 1995;37:766-76.
29. Fornani MC, Pedreira S, Niveloni S, et al. Proinflammatory cytokines might have a role in the pathology of celiac disease: Pre-and post-treatment serum levels of cytokines IL-1beta, IL-6, and IL-1 receptor antagonist in coeliac disease. Are they related to the associated osteopenia? Am J Gastroenterol 1998;93:413-8.